Ignite Creation Date:
2024-05-06 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04714996
Status:
RECRUITING
Last Update Posted:
2023-03-02
First Post:
2021-01-13
Brief Title:
Efficacy Safety and Pharmacokinetics of ES-481 in Adult Patients With Drug Resistant Epilepsy
Sponsor:
ES Therapeutics Australia Pty Ltd
Organization:
ES Therapeutics Australia Pty Ltd
Study Overview
Official Title:
A Phase 2A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy Safety and Pharmacokinetics of ES-481 in Adult Patients With Drug Resistant Epilepsy
Status:
RECRUITING
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a Phase 2a Randomized Double-Blind Placebo-Controlled Study with cross-over to Evaluate the Efficacy Safety and Pharmacokinetics of ES-481 in Adult Patients with Drug Resistant Epilepsy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None